Genesis Research Group is one of the leading evidence generation consultancies providing agile, tech-enabled real-world evidence (RWE), as well as health economics and outcomes research (HEOR) solutions to clients in the pharmaceutical, biotech, and medical device industries. Since 2009, we’ve partnered with our clients to develop impactful evidence across the product lifecycle to optimize market access for novel healthcare innovations and satisfy regulatory, provider, and payer evidence requirements.
Genesis is database agnostic, regularly working across many structured and unstructured real-world data sources. As a company, we deliver services across many RWE and HEOR applications and a wide range of therapeutic areas with an emphasis on uncompromising quality, scientific rigor, and flexible solutions.
The Genesis Research Group pharmacoepidemiology and safety team consists of scientific experts who lead study design, methodology development, and result interpretation across a broad range of regulatory and safety RWE studies. The individual in this role will demonstrate a passion for the generation of rigorous and relevant RWE, ensuring delivery of high-quality evidence in a timely manner to fully meet our clients’ needs. This position will report to a Director or Senior Director in Pharmacoepidemiology and Safety.
Flexible – hybrid or remote, depending on location.
